Mary K Densley, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 166 Bay Spring Ave, Barrington, RI 02806 Phone: 401-372-7014 Fax: 401-336-2442 |
Ashley Meizoso, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 166 Bay Spring Ave, Barrington, RI 02806 Phone: 401-359-4898 |
Mrs. Nicole Braga-o'neill, M.S., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 166 Bay Spring Ave, Barrington, RI 02806 Phone: 401-359-4898 |
Mrs. Nancy Jeanverrier Voigt, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 283 County Rd, Barrington, RI 02806 Phone: 401-247-3145 |
Jamie Michelle Maymon, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 166 Bay Spring Ave, Barrington, RI 02806 Phone: 401-359-4898 Fax: 401-336-2442 |
Lisa M Sestito Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 283 County Rd, Special Education Department, Barrington, RI 02806 Phone: 401-247-3145 |
Mrs. Marian Morey, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 283 County Rd, Special Education Dept., Barrington, RI 02806 Phone: 401-247-3145 |
News Archive
Today, at the 43rd Annual Meeting & Exhibition of the American Association for Dental Research, held in conjunction with the 38th Annual Meeting of the Canadian Association for Dental Research, R. Constance Wiener, from West Virginia University, Morgantown, will present a research study titled "Association of Tooth Loss and Depression and Anxiety."
Loyola University Chicago Health Sciences students, faculty and staff will participate in simulations to help them better understand what it is like to live in poverty.
In 2018, cyanobacteria from nutrient-rich waters in Lake Okeechobee were released down the Caloosahatchee river at the same time that red tides were gathering along the Florida west coast, potentially exposing coastal residents to a mixture of toxins.
For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children.
› Verified 1 days ago